Your browser doesn't support javascript.
loading
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution.
Montero, Nuria; Toapanta, Néstor; Pallarès, Natàlia; Crespo, Marta; Diekmann, Fritz; Guirado, Lluis; Esteban, Rafael; Codina, Sergi; Melilli, Edoardo; Buxeda, Anna; Velis, Gonzalo; Torres, Irina B; Revuelta, Ignacio; Molina Andujar, Alicia; Facundo, Carme; Bardají, Beatriz; Riera, Lluís; Fiol, Maria; Cruzado, Josep M; Comas, Jordi; Giral, Magali; Naesens, Maarten; Åsberg, Anders; Moreso, Francesc; Bestard, Oriol.
Afiliação
  • Montero N; Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Toapanta N; Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.
  • Pallarès N; Biostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Crespo M; Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Diekmann F; Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.
  • Guirado L; Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.
  • Esteban R; Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Codina S; Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Melilli E; Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Buxeda A; Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Velis G; Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Torres IB; Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.
  • Revuelta I; Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.
  • Molina Andujar A; Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.
  • Facundo C; Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.
  • Bardají B; Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.
  • Riera L; Urology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Fiol M; Urology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Cruzado JM; Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
  • Comas J; Catalan Organ Transplant Organization, Barcelona, Spain.
  • Giral M; CRTI UMR 1064, Inserm, Université de Nantes, ITUN, CHU Nantes, RTRS Centaure, Nantes, France.
  • Naesens M; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.
  • Åsberg A; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • Moreso F; Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Bestard O; Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.
Transpl Int ; 34(12): 2494-2506, 2021 12.
Article em En | MEDLINE | ID: mdl-34626501
Outcomes of kidney transplantation (KT) after controlled circulatory death (cDCD) with highly expanded criteria donors (ECD) and recipients have not been thoroughly evaluated. We analyzed in a multicenter cohort of 1161 consecutive KT, granular baseline donor and recipient factors predicting transplant outcomes, selected by bootstrapping and Cox proportional hazards, and were validated in a contemporaneous European KT cohort (n = 1585). 74.3% were DBD and 25.7% cDCD-KT. ECD-KT showed the poorest graft survival rates, irrespective of cDCD or DBD (log-rank < 0.001). Besides standard ECD classification, dialysis vintage, older age, and previous cardiovascular recipient events together with low class-II-HLA match, long cold ischemia time and combining a diabetic donor with a cDCD predicted graft loss (C-Index 0.715, 95% CI 0.675-0.755). External validation showed good prediction accuracy (C-Index 0.697, 95%CI 0.643-0.741). Recipient older age, male gender, dialysis vintage, previous cardiovascular events, and receiving a cDCD independently predicted patient death. Benefit/risk assessment of undergoing KT was compared with concurrent waitlisted candidates, and despite the fact that undergoing KT outperformed remaining waitlisted, remarkably high mortality rates were predicted if KT was undertaken under the worst risk-prediction model. Strategies to increase the donor pool, including cDCD transplants with highly expanded donor and recipient candidates, should be performed with caution.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Sobrevivência de Enxerto Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Sobrevivência de Enxerto Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article